HBK Investments’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

HBK Investments’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-374,925	Closed	-$23.3M	–	260
2023 Q4	$23.3M	Buy	+374,925	New	+$9.32M	0.11%	36

HBK Investments's RYZB Position: Q1 2024 in Review

HBK Investments sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 374,925 shares — an estimated $23.3M sold.

HBK Investments first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $23.3M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

HBK Investments reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HBK Investments sold 374,925 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $23.3M.
HBK Investments first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
HBK Investments's RayzeBio, Inc. Common Stock position peaked at $23.3M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on HBK Investments's 13F filing for Q1 2024, filed 15 May 2024.